In this study, we apply whole-exome sequencing (WES) on 53 TFE3-tRCCs and RNA sequencing (RNA-seq) on 63 TFE3-tRCCs to reveal their genomic and transcriptomic characteristics and discover molecular mechanisms potentially involved in tumor progression. The gene discussed is TFE3; the disease is neoplasm.